Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 20
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Clin Pharm Ther ; 42(4): 502-505, 2017 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-28488314

RESUMO

WHAT IS KNOWN AND OBJECTIVE: Neuroleptic malignant syndrome (NMS) is a rare but severe adverse effect of antipsychotic drugs. CASE DESCRIPTION: We report two cases of NMS highlighted by clinical pharmacists in an emergency unit during summer. One of them was fatal. Medication reconciliation processes performed at admission identified treatment with loxapine for one of them and with loxapine and clozapine for the other. Interview of the patients highlighted clinical symptoms suggesting NMS, allowing the pharmacists to alert the medical team. WHAT IS NEW AND CONCLUSION: Adverse drug events may be severe and clinical pharmacists in emergency departments can help to detect them.


Assuntos
Antipsicóticos/efeitos adversos , Síndrome Maligna Neuroléptica/diagnóstico , Farmacêuticos/organização & administração , Idoso , Antipsicóticos/administração & dosagem , Clozapina/administração & dosagem , Clozapina/efeitos adversos , Serviço Hospitalar de Emergência/organização & administração , Evolução Fatal , Humanos , Loxapina/administração & dosagem , Loxapina/efeitos adversos , Masculino , Pessoa de Meia-Idade , Síndrome Maligna Neuroléptica/etiologia , Serviço de Farmácia Hospitalar/organização & administração , Papel Profissional
2.
Rev Med Interne ; 37(2): 84-90, 2016 Feb.
Artigo em Francês | MEDLINE | ID: mdl-26302696

RESUMO

PURPOSE: The diagnostic value of selective anorexia is debated. Some authors have suggested an association between meat aversion and cancer, but most do not use it as a diagnostic tool. We aimed to characterize anorexia of different diseases to search for an association between selective aversions and diagnostic groups. METHODS: All the patients admitted to three departments of a teaching hospital were included consecutively for 22months if they had more than 10 % weight loss in less than one year. Patients were excluded if history taking was not reliable, or if they suffered from anorexia nervosa. We compiled diagnoses at discharge and validated them six months later. We used logistic regression to identify independent factors associated with selective anorexia. RESULTS: Inclusion criteria were met in 106patients (female 44 %, median age 65years). Most frequent diagnoses were: cancer (36 %), infection (35 %), digestive diseases (19 %), non organic diseases (21 %). Recent selective anorexia was found in 46 % of the cases. It was significantly associated with female gender (P=0.002), marginally with young age (P=0.069) and long duration of weight loss (P=0.079). Opioid use at admission was negatively associated with selective anorexia (P=0.001). No specific diagnostic category was found to be associated. CONCLUSION: Selective anorexia does not appear to be a useful symptom to investigate pathological weight loss. It behaves more like a non-specific reactivation by current disease of earlier latent personal food aversions.


Assuntos
Anorexia/etiologia , Avaliação de Sintomas , Paladar , Redução de Peso , Idoso , Idoso de 80 Anos ou mais , Anorexia/classificação , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Inquéritos e Questionários
3.
Rev Med Interne ; 31(3): 188-93, 2010 Mar.
Artigo em Francês | MEDLINE | ID: mdl-20053487

RESUMO

PURPOSE: Misuse of high-dose buprenorphine (HDB), mainly by injection, is responsible of frequent infectious adverse events. METHODS: This is a retrospective study of infectious complications occurring in patients using HDB by injection. Forty-two cases were identified (29 men and ten women) and the data were collected between March 1999 and December 2008. RESULTS: The infectious complications included cutaneous infections (27 cases), endocarditis (nine cases), osteoarticular infections (four spondylodiscitis and one sacroiliitis), and a vascular embolism with decrease in visual acuity. CONCLUSION: The results of HDB maintenance treatment must be improved, both from the point of view of substitution and to limit its misuse by intravenous route injection. Health professionals have to play an important role in drug addict patients' education and supervision, to prevent buprenorphine injection and related infectious complications.


Assuntos
Infecções Bacterianas/etiologia , Buprenorfina/administração & dosagem , Injeções Intravenosas/efeitos adversos , Injeções Subcutâneas/efeitos adversos , Antagonistas de Entorpecentes/administração & dosagem , Abscesso/etiologia , Adulto , Discite/etiologia , Relação Dose-Resposta a Droga , Endocardite Bacteriana/etiologia , Feminino , Dependência de Heroína/reabilitação , Humanos , Masculino , Estudos Retrospectivos
4.
Acta Paediatr ; 97(10): 1358-61, 2008 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-18644009

RESUMO

AIM: To compare the duration of treatment for neonatal abstinence syndrome (NAS) using chlorpromazine versus morphine hydrochloride. METHODS: We compared two case series of term infants with NAS treated with either morphine hydrochloride (MH) or chlorpromazine (CP). Seventeen infants were treated with MH from 1998 to 1999, and 20 infants were managed with CP from 2000 to 2001. The duration of treatment was compared, and multivariate analysis was used to identify independent risk factors related to the duration of treatment. RESULTS: Characteristics of the mothers (duration of drug addiction, abuse of other substances) and infants (birth weight, proportion breastfed) were similar in the two groups. The mean duration of CP treatment was 6 days (range 3.5-9 days), significantly fewer days than with MH treatment, which was 16 days (range 10-21 days; p < 0.001). There were fewer hospitalization days (11 days; range 9-14 days) for CP treatment compared with MH-treated infants (18 days; range 16-25 days). Treatment with CP was independently associated with shorter hospitalization time. CONCLUSION: CP appears to shorten the duration of NAS compared with MH. Larger prospective randomized trials are needed to confirm our findings.


Assuntos
Antieméticos/uso terapêutico , Clorpromazina/uso terapêutico , Antagonistas de Dopamina/uso terapêutico , Morfina/uso terapêutico , Antagonistas de Entorpecentes/uso terapêutico , Síndrome de Abstinência Neonatal/tratamento farmacológico , Feminino , Humanos , Recém-Nascido , Masculino , Síndrome de Abstinência Neonatal/terapia , Índice de Gravidade de Doença , Síndrome de Abstinência a Substâncias/etiologia , Fatores de Tempo
8.
Rev Med Interne ; 22(3): 297-303, 2001 Mar.
Artigo em Francês | MEDLINE | ID: mdl-11270274

RESUMO

INTRODUCTION: We report three cases of neurotoxicity in patients with renal failure, treated with Zelitrex (valacyclovir). EXEGESIS: The patients are two women and a man, aged 76 +/- 4.6 years, who presented acute mental confusion during a treatment with valacyclovir. In two cases, the patients previously had altered renal function and were under peritoneal dialysis. In the last case, the patient had simultaneous neurotoxicity and acute renal failure. After the discontinuation of the drug, the outcome was favourable in all cases. CONCLUSION: Our cases focus attention on the possible neurotoxicity of valacyclovir, which is an amino acid ester prodrug of acyclovir, rapidly and almost completely hydrolysed to acyclovir prior to systemic exposure. The bioavailability of valacyclovir is 54% compared to approximately 20% for oral acyclovir and may account for unexpected overdoses, which may lead to serious neurological toxicity.


Assuntos
Aciclovir/análogos & derivados , Aciclovir/efeitos adversos , Transtornos Mentais/induzido quimicamente , Pró-Fármacos/efeitos adversos , Valina/análogos & derivados , Valina/efeitos adversos , Aciclovir/farmacocinética , Idoso , Idoso de 80 Anos ou mais , Disponibilidade Biológica , Overdose de Drogas , Feminino , Humanos , Masculino , Pró-Fármacos/farmacocinética , Insuficiência Renal/tratamento farmacológico , Valaciclovir , Valina/farmacocinética
10.
14.
Ann Med Interne (Paris) ; 146(7): 505-9, 1995.
Artigo em Francês | MEDLINE | ID: mdl-8787293

RESUMO

The treatment and the prevention of Pneumocystis carinii pneumonia (PCP) is based on trimethoprim-sulfamethoxazole. However, hypersensitivity reactions occur often in HIV-infected patients. In this study, clinical and biological parameters of 27 PCP-patients treated by this drug association were analyzed. We divided the drug reactions into two groups according to the severity. A drug reaction occurred in 59.2% of the patients and was note as a mild reaction in 18.5% of the cases and as a severe reaction in 40.7%. An initial high eosinophil count was noted in patients who may present future drug reaction. This difference was more significant in patients who may present severe drug reaction. No other clinical or biological factors were predictive of hypersensitivity. The immune status of HIV-disease, drug therapy, and drug mechanisms were discussed.


Assuntos
Infecções Oportunistas Relacionadas com a AIDS/tratamento farmacológico , Hipersensibilidade a Drogas/etiologia , Pneumonia por Pneumocystis/tratamento farmacológico , Combinação Trimetoprima e Sulfametoxazol/efeitos adversos , Adulto , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Valor Preditivo dos Testes , Estudos Retrospectivos , Fatores de Risco
17.
Arch Mal Coeur Vaiss ; 86(1): 27-34, 1993 Jan.
Artigo em Francês | MEDLINE | ID: mdl-8338397

RESUMO

The prognosis of right ventricular failure in patients with mitral valve disease would seem to depend on its chronicity and progression according to the results of a study of 382 cases of mitral valve disease: 231 women, 151 men: average age 55 +/- 13 years, operated between January 1983 and December 1986, most (321) for mitral valve replacement, one third (108) with associated aortic valve replacement. Right ventricular failure was or had been present before surgery in 161 patients: the peri-operative mortality was 11.2% and the secondary mortality 21.7% in these cases, significantly higher than in patients without RVF (respectively 5.0%, p = 0.02, and 8.1%, p < 0.0005). The RVF was present in the immediate post-operative phase in 43 patients, 8 of whom had no signs of this complication beforehand. The cause of this "de novo" early RVF is multifactorial. Ten other patients developed secondary RVF without any obvious cause in 3 cases. The prognosis of "de novo" RVF is very poor (28% survivors at 75 months). At the end of 60.4 +/- 13.6 months 20 patients were lost to follow-up, RVF was present in 60/286 patients followed up. The mortality was high in the patients with residual RVF (38.3% vs 4.0% in patients without: p < 0.0001). This study confirms the poor prognosis of RVF in patients with mitral valve disease whatever the timing with respect to surgery. Right ventricular failure occurring for the first time after surgery is rare (4.7% of cases), of uncertain cause, and carries a particularly poor prognosis.


Assuntos
Insuficiência Cardíaca/etiologia , Doenças das Valvas Cardíacas/complicações , Próteses Valvulares Cardíacas/efeitos adversos , Função Ventricular Direita , Análise Atuarial , Adulto , Idoso , Valva Aórtica/cirurgia , Feminino , Insuficiência Cardíaca/mortalidade , Doenças das Valvas Cardíacas/cirurgia , Humanos , Masculino , Pessoa de Meia-Idade , Valva Mitral/cirurgia , Prognóstico , Estudos Retrospectivos , Taxa de Sobrevida
19.
Pathol Res Pract ; 188(4-5): 466-72, 1992 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-1409073

RESUMO

In this prospective study, an image cytometric DNA-analysis was performed in 86 women with breast neoplasms (72 primary invasive carcinomas and 14 benign lesions). Four DNA ploidy parameters were analysed: histogram type (according to AUER classification), DNA-index, tumor cells with DNA content above the 5n limit and DNA malignancy grade (DNA-MG, calculation according to Böcking). Their correlations with well established prognostic factors in breast carcinomas (tumor size, lymph node status, histologic grade, hormone receptor content) were studied. All but one benign lesions were diploid (13/14 cases), whereas the majority of the primary invasive breast carcinomas were aneuploid (58/72 cases). A predominance of carcinomas with a percentage of cells superior or equal to 1% with DNA content above the 5n limit was observed (54 cases out of 58). Most of the aneuploid tumors had a histogram type III or IV (53 cases) or a high DNA-index (50 cases). Of these 58 aneuploid cases, only 26 tumors had a DNA-MG superior to 1. Interestingly, 26 tumors had the 4 criteria of aneuploidy, 19 had 3 and 9 had 2 and only 4 tumors had one parameter. The DNA-MG was significantly related to hormonal receptors (p less than 0.001) and tumor size (p less than 0.01). The histogram types (Auer classification) and the DNA content above the 5n limit were correlated with histologic grade (SBR or SBRM) (p less than 0.02). Concerning the DNA-index no correlation was observed with well established prognostic factors. On the other hand no significant correlation was found between these new biologic variables and lymph node status.(ABSTRACT TRUNCATED AT 250 WORDS)


Assuntos
Aneuploidia , Neoplasias da Mama/genética , Carcinoma de Células de Transição/genética , DNA de Neoplasias/análise , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Neoplasias da Mama/epidemiologia , Neoplasias da Mama/patologia , Carcinoma de Células de Transição/epidemiologia , Carcinoma de Células de Transição/patologia , Feminino , Citometria de Fluxo/métodos , Humanos , Processamento de Imagem Assistida por Computador/métodos , Linfonodos/patologia , Pessoa de Meia-Idade , Ploidias , Estudos Prospectivos , Fase S
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...